Skip to main content

Find Clinical Trials

Home
Conditions
Extensive Macular Atrophy With Pseudodrusen (EMAP)

Clinical trial condition

Extensive Macular Atrophy With Pseudodrusen (EMAP)

Explore clinical trials studying Extensive Macular Atrophy With Pseudodrusen (EMAP). Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Extensive Macular Atrophy With Pseudodrusen (EMAP) trial results

Active, Not Recruiting

Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases

NCT07341919

Conditions: Anetoderma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations: Centro Especializado Retina e Vítreo São José do Rio Preto, São Paulo, Brazil

View Trial Details

Active, Not Recruiting

Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases

NCT07348588

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Extensive Macular Atrophy With Pseudodrusen (EMAP), Eye Diseases, +7 more
Locations: Rubens Siqueira Research Center São José do Rio Preto, São Paulo, Brazil

View Trial Details